Previous Close | 0.3675 |
Open | 0.3675 |
Bid | 0.3701 x 4000 |
Ask | 0.3800 x 3200 |
Day's Range | 0.3559 - 0.3800 |
52 Week Range | 0.3300 - 1.9400 |
Volume | |
Avg. Volume | 372,941 |
Market Cap | 28.382M |
Beta (5Y Monthly) | 7.96 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.5910 |
Earnings Date | Mar 29, 2022 - Apr 04, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 3.00 |
China is one of the leading markets globally for insect repellantsHENRIETTA, N.Y., June 07, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced Global BioLife, Inc. (“Global BioLife”), a division of the Company’s wholly
By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT This quarter is the first reported with the consolidation of Sharing Global Services to the income statement. It has a March fiscal year so we have not yet seen its Q4 but we expect it added about $6 million to revenues and $2 million to losses (excluding the $1.5 million write-down.) As expected, its addition put DSS (NYSE:DSS) back in
ROCHESTER, N.Y., May 06, 2022 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating businesses within nine divisions and strategically acquiring and developing assets to enrich the value of its shareholders through calculated IPO spinoffs and a parametric share distribution strategy, today announced that an interview with Chief Operating Officer, Jason Grady, will air on The RedChip Money Report® on Bloomberg U.S., this Saturday May 7th, at 7 p.m. Eastern Time (ET